JP2002528410A5 - - Google Patents

Download PDF

Info

Publication number
JP2002528410A5
JP2002528410A5 JP2000577997A JP2000577997A JP2002528410A5 JP 2002528410 A5 JP2002528410 A5 JP 2002528410A5 JP 2000577997 A JP2000577997 A JP 2000577997A JP 2000577997 A JP2000577997 A JP 2000577997A JP 2002528410 A5 JP2002528410 A5 JP 2002528410A5
Authority
JP
Japan
Prior art keywords
radiation therapy
therapy treatment
cancer
use according
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000577997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002528410A (ja
JP4685242B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA1999/000994 external-priority patent/WO2000024387A2/en
Publication of JP2002528410A publication Critical patent/JP2002528410A/ja
Publication of JP2002528410A5 publication Critical patent/JP2002528410A5/ja
Application granted granted Critical
Publication of JP4685242B2 publication Critical patent/JP4685242B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000577997A 1998-10-22 1999-10-22 ヒアルロン酸を用いた放射線膀胱炎の予防、軽減、および治療法 Expired - Lifetime JP4685242B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10518498P 1998-10-22 1998-10-22
US60/105,184 1998-10-22
PCT/CA1999/000994 WO2000024387A2 (en) 1998-10-22 1999-10-22 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid

Publications (3)

Publication Number Publication Date
JP2002528410A JP2002528410A (ja) 2002-09-03
JP2002528410A5 true JP2002528410A5 (enExample) 2007-08-30
JP4685242B2 JP4685242B2 (ja) 2011-05-18

Family

ID=22304511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000577997A Expired - Lifetime JP4685242B2 (ja) 1998-10-22 1999-10-22 ヒアルロン酸を用いた放射線膀胱炎の予防、軽減、および治療法

Country Status (12)

Country Link
US (2) US6667296B1 (enExample)
EP (1) EP1124546B1 (enExample)
JP (1) JP4685242B2 (enExample)
AT (1) ATE264674T1 (enExample)
AU (1) AU761158B2 (enExample)
CA (1) CA2347110C (enExample)
DE (1) DE69916643T2 (enExample)
DK (1) DK1124546T3 (enExample)
ES (1) ES2219070T3 (enExample)
NZ (1) NZ511068A (enExample)
PT (1) PT1124546E (enExample)
WO (1) WO2000024387A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906619D0 (en) 1999-03-23 1999-05-19 Zeneca Resins Bv Compositions
US20070173479A1 (en) * 2003-12-10 2007-07-26 Keryx Biopharmaceuticals, Inc. Methods Using Sulodexide for the Treatment of Bladder Disease
JP2007233949A (ja) * 2006-03-03 2007-09-13 Kyoto Univ 排尿管理システム
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
EP3960215B1 (en) 2009-12-15 2024-10-16 Incept, LLC Implants and biodegradable fiducial markers
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
WO2016146573A1 (en) * 2015-03-13 2016-09-22 Repoceuticals Aps Melatonin for preventing and treating radiation cystitis
RU2676431C1 (ru) * 2018-02-26 2018-12-28 Федеральное государственное бюджетное учреждение "Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова" Министерства здравоохранения Российской Федерации (ФГБУ "РНЦРХТ им. ак. А.М. Гранова" Минздрава России) Способ моделирования лучевого цистита
WO2019236453A1 (en) * 2018-06-03 2019-12-12 Glycomira Therapeutics, Inc. Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and /or chemotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN181358B (enExample) * 1995-02-14 1998-05-30 Bioniche Inc
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
CA2154103C (en) 1995-07-18 1998-02-24 Samuel Simon Asculai Treatment of mucous membrane disease, trauma or condition and for the relief of pain
WO1998029125A1 (fr) * 1996-12-27 1998-07-09 Seikagaku Corporation Remedes contre des troubles de la vessie

Similar Documents

Publication Publication Date Title
JP2001515712A5 (enExample)
ZA971020B (en) Colonic delivery of nicotine to treat inflammatory bowel disease.
JP2002528410A5 (enExample)
AU5090796A (en) Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
CA2430692A1 (en) Geldanamycin derivative and use of same to treat cancer
JP2003501488A5 (enExample)
WO2001080843A3 (en) Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
IL211288A (en) Medical vaginal preparations to reduce or relieve uterine rhythm, and use of anti-arrhythmic therapy in the preparation of vaginal drugs to reduce or relieve uterine rhythm
IL145492A0 (en) Methods and compositions for treating solid tumors
NZ569331A (en) COP 1 for treatment of inflammatory bowel diseases
JP2002524415A5 (enExample)
JP2003533479A5 (enExample)
PT1214077E (pt) Libertacao local de estradiol 17-beta para melhorar a funcao vascular do endotelio na sequencia de feridas vasculares
EP1889614A3 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
WO2001024783A3 (de) Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
CA2401000A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
JP2004510816A5 (enExample)
JP2002523437A5 (enExample)
CA2283255A1 (en) Use of r-nsaid's for the prevention of alzheimer's disease
CA2221900A1 (en) Use of trospium chloride and 2-component system for the same
IL143985A0 (en) New use of melagatran
AU2003290015A1 (en) Mastitis treatment
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
EP0799618A3 (en) Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer